Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
We report the case of a 50-year-old woman with severe palmoplantar psoriasis who developed alopecia areata (AA) 2 months after initiating treatment with tildrakizumab (100 mg subcutaneously). The patient had no personal or familial history of autoimmune disorders, and the diagnosis of AA was confir...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2026-01-01
|
| Edice: | Dermatology Reports |
| Témata: | |
| On-line přístup: | https://journals.pagepress.net/dr/article/view/10240 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|